Analytical Data
-
Gene name
AHNAK2
- Application
-
Alternative Names
C14orf78
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IVF2
-
Expression Region
Met1~Gly483
-
Molecular Weight
70kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AHNAK2, a member of the AHNAK family of proteins, plays a crucial role in various cellular processes, including cell adhesion, migration, and signaling. Research into AHNAK2 has garnered attention due to its involvement in the development and progression of several diseases, particularly cancers. This protein acts as a scaffolding molecule, interacting with different partners such as ion channels and signaling proteins, thus influencing cellular functions and providing insights into tissue development and repair mechanisms. Its expression patterns have been linked to tumorigenesis, making AHNAK2 a potential biomarker for certain malignancies. Furthermore, studies indicate that manipulating AHNAK2 levels can affect cellular behavior, underscoring its potential as a therapeutic target. Given these aspects, the recombinant production of AHNAK2 has become a focal point of research, enabling scientists to explore its functional mechanisms in detail, assess its role in disease pathogenesis, and evaluate its potential in clinical applications. The exploration of AHNAK2 not only enhances our understanding of fundamental biological processes but also paves the way for novel strategies in disease treatment and management.
